BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential

BenzingaNov 10 03:12

This Bank of America Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

BenzingaNov 8 21:01

Goldman Sachs Upgrades BioNTech(BNTX.US) to Buy Rating, Raises Target Price to $137

Futu NewsNov 8 13:33 · Ratings

Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'

BenzingaNov 8 04:07

Breaking Down BioNTech: 16 Analysts Share Their Views

BenzingaNov 7 04:00

Vaccine Stocks Drop on Worries About an RFK Jr. Role -- WSJ

WSJNov 7 02:15